Neurocrine Biosciences, Inc. (NBIX) vs Repligen Corporation (RGEN)
Detailed comparison between Neurocrine Biosciences, Inc., Repligen Corporation.Total Return (%)
Neurocrine Biosciences, Inc. (NBIX)Repligen Corporation (RGEN)
Which stock do you think will perform better?
Neurocrine Biosciences, Inc.
NBIX
Repligen Corporation
RGEN
| Metric | Neurocrine Biosciences, Inc. (NBIX) | Repligen Corporation (RGEN) |
|---|---|---|
| Current Price | $119.11 | $164.74 |
| Change | -1.58 (-1.31%) | 5.75 (3.62%) |
| Market Cap | $11.88B | $9.23B |
| Trailing P/E | 36.20 | 0.00 |
| Forward P/E | 19.18 | 92.55 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $157.98 | $203.13 |
| 52-Week Low | $110.95 | $113.50 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $3.29 | $-0.46 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| NBIX | -19.62% | -19.62% | -12.15% | 26.78% | 197.40% | 200.86% |
| RGEN | -1.95% | -1.95% | -14.10% | 93.45% | 528.78% | 536.55% |